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Introduction
Fetal bradycardia is a rare condition that is identified
during prenatal ultrasound surveys, and misdiagnosis
in outpatient departments is not uncommon. Fetal
bradycardia at an early gestational age inevitably leads
to fetal loss, and nonimmune fetal hydrops or anasarca
is noticeable, while cardiac decompensation develops.
Obscure clinical prenatal manifestations of fetal brady-
cardia can be difficult to differentiate from transient
variations of fetal heart deceleration. Some cases of
fetal bradycardia show complete atrioventricular block
related to maternal autoimmune disease, especially
systemic lupus erythematosus (SLE). Administration of
an appropriate treatment is crucial in order to avoid
irreversible consequences.
Case Report
A 38-year-old female, gravida 3, para 2, received reg-
ular antenatal examination and had no complications
until 32 weeks’ gestation, at which time routine ultra-
sound revealed suspicious fetal bradycardia (117 bpm)
and a bi-parietal diameter of 80 mm, which was con-
sistent with gestational age. No intrauterine growth
restriction or severe bradycardia was detected during
subsequent examinations. Persistent fetal bradycardia
(< 100 bpm) was identified after advanced sonographic
examination at 37 weeks’ gestation. Repeat ultra-
sound showed severe bradycardia (53 bpm), bilateral
hydrocele, and polyhydramnios at 37 weeks’ gestation
(Figures 1–3). We performed caesarean section for
the mother, and a male infant weighing 3,590 g, with
Apgar scores of 8 and 9 at 1 and 5 minutes, was de-
livered. Cardiac evaluation revealed an atrial rate of
120 bpm and a ventricular rate of 62 bpm. Third-degree
atrioventricular block was identified using 12-lead
electrocardiography (Figure 4). The newborn was im-
mediately sent to the neonatal intensive care unit for a
transvenous pacemaker to be fitted. During admission,
the heart rate was controlled at around 100–120 bpm,
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determined by the newborn’s state of well-being (Fig-
ure 5). Intravenous immunoglobulin (IVIG) was admini-
stered for 4 days. However, fever was noted and blood
culture showed methicillin-resistant Staphylococcus aureus
on day 13, after which vancomycin was administered.
The baby’s parents refused fitting of a permanent pace-
maker after completion of the course of antibiotics. At
the last follow-up, the heart rate was 73 bpm. No deve-
lopmental retardation or cyanotic change was noticed
during subsequent examinations.
Discussion
Persistent fetal bradycardia is a rare condition during
pregnancy, with an incidence as low as 1 in 20,000 to
25,000 live births [1–4]. However, the actual incidence
must be higher when allowing for intra-uterine fetal
death caused by cardiac decompensation (hydrops).
It may be possible to predict abnormal fetal cardiac
rhythm on detection of an irregular or slow heart rate at
an early gestational age.
Most obstetricians, however, pay little attention
to fetal bradycardia during early gestation. The median
gestational age at referral for fetal complete heart block
(CHB) is 26 weeks, but this ranges from 17 to 38 weeks’
gestation [5]. If fetal bradycardia is noted, it is important
to differentiate this from structural heart diseases. A
previous report has revealed that more than 50% of CHB
is seen in association with severe congenital heart disease
[5].
The first case of CHB in a fetus was reported in 1945
[6]. A previous report had suggested that transplacental
passage of some factor present in maternal serum was
responsible for this [7]. A positive association between
fetal CHB and maternal collagen vascular disease has
also been reported [8]. SS-A (anti-Ro antibody) and SS-
B (anti-La antibody) play key roles in the association
between fetal CHB and specific maternal antibodies
that circulate in numerous maternal collagen vascular
diseases [9–12]. In the case reported here, neither a
specific maternal medical condition nor abnormal fetal
development was noticed during pregnancy.
In the literature, hydrocele is commonly associated
with hydrops, meconium peritonitis, maternal puerperal
sepsis, and inflammation of Meckel’s diverticulum
[13–15]. Hydrocele is commonly identified prenatally
on ultrasound during the third trimester [16]. In one
study, 123 fetuses were imaged between 27 and 41
weeks’ gestation. Scrotal hydrocele was identified in 19
fetuses [16], of which only one required surgery at 16
months of age. Fourteen babies were normal at post-
natal follow-up, but four babies were not followed-up.
Figure 1. M-mode echocardiogram recorded at 37 weeks’
gestation. Complete atrioventricular block was detected (atrial
rate, 109 bpm; ventricular rate, 53 bpm). A = atrial contraction;
V = ventricular contraction.
Figure 3. Apparent polyhydramnios with AVI of 41.75 cm
(37 weeks’ gestation).
Figure 2. Fetal scrotal hydrocele diagnosed by ultrasound at
37 weeks’ gestation, left side picture.
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The infant that required surgery also had hydrocephalus.
In our case, no hydrocephalus or signs of hydrops
were found. Bilateral hydrocele may have resulted
from mild decompensation of cardiac function, which
possibly caused hydrops fetalis. Furthermore, the
reported polyhydramnios could have resulted from
the diuretic effect of body fluid overload. Although no
hydrops was identified, it was difficult to decide how
to deliver this baby with severe bradycardia (ventricular
rate, 53 bpm). We performed cesarean section to pre-
vent further deterioration of the fetal cardiovascular
system and fetal distress.
Prenatal medical therapies for fetal bradycardia
are divided into two categories. One strategy is to
minimize the immunologic injury to the fetal heart and
the other is to increase the fetal heart rate. We did not
Figure 4. First electrocardiogram after birth: complete atrioventricular block in all leads, especially in long lead II. Red arrow =
P wave; black arrow = QRS wave; red broken-line arrow = ventricular premature contraction.
Figure 5. Relatively regular cardiac rhythm after placement of a transient transvenous pacemaker (~ 120 bpm).
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use aggressive treatment because there was no apparent
fetal distress. However, prenatal fetal therapy with
maternal steroids, intravenous a-globulin, `-mimetic
agents, and plasmapheresis could have been con-
sidered. The immunosuppressive effects of steroids and
intravenous a-globulin could have prevented further
transplacental passage of immunoglobulin occurring
after 22 weeks of gestation, which correlates with
progressive immune-mediated injury to the fetal
conduction system [17].
In this case, we administered IVIG for 4 days to the
newborn. Unfortunately, it is difficult to assess whether
the IVIG was effective or not after CHB had been
diagnosed.
Investigation of the history of the mother revealed
suspected symptoms and signs of rheumatoid arthritis,
including morning stiffness and arthralgia. Rheumatoid
factor and antinuclear antibody were positively iden-
tified about 5 years previously, and she was suspected
of having rheumatoid arthritis. However, she did not
continue follow-up because no further exaggerating
symptoms and signs were noticed. No definite auto-
immune disease was diagnosed at that time. During the
admission, an autoimmune study disclosed elevated
erythrocyte sedimentation rate, positive rheumatoid
factor, antinuclear antibody, and anti-Ro antibody in
the mother, as well as positive antinuclear antibody and
anti-Ro antibody in the newborn.
Fetal bradycardia could be the first manifestation of
maternal collagen vascular disease, which would not
necessarily be SLE. Early administration of steroid, a-
globulin, or maternal plasmapheresis could prevent
further damage to the fetal cardiac conduction system,
if a high level of maternal anti-Ro antibody or anti-La
antibody is discovered. In our case, instead of post-
partum status, we should have checked the profiles of
autoimmune disease at 32 weeks’ gestation when
bradycardia was suspected.
In conclusion, SLE as well as other autoimmune
diseases with SS-A could result in fetal CHB. Hence, an-
tenatal evaluation for a maternal history of autoimmune
disease (especially SLE) and prevention of fetal brady-
cardia by reducing immune-mediated injuries on the
cardiac conduction system are important.
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